Long noncoding RNAs in cancer-immunity cycle

被引：119
作者：
Yu, Wei-Di [1 ,2 ]
Wang, Huanhuan [3 ]
He, Qi-Feng [1 ,2 ]
Xu, Yong [4 ,5 ]
Wang, Xiao-Chen [1 ,2 ]
机构：
[1] Nanjing Med Univ, Affiliated Hosp 1, Liver Transplantat Ctr, Nanjing 210029, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Nanjing 210029, Jiangsu, Peoples R China
[3] Dongnan Univ, Affiliated Xuzhou Ctr Hosp, Nursing Dept, Xuzhou, Jiangsu, Peoples R China
[4] Xuzhou Med Univ, Huaian Peoples Hosp 2, Dept Nephrol, Huaian 223001, Jiangsu, Peoples R China
[5] Xuzhou Med Univ, Affiliated Huaian Hosp, Dept Nephrol, Huaian 223001, Jiangsu, Peoples R China
来源：
JOURNAL OF CELLULAR PHYSIOLOGY | 2018年 / 233卷 / 09期
关键词：
cancer; cancer-immunity cycle; immunity; lncRNA; T-CELL DIFFERENTIATION; PD-1/PD-L1; BLOCKADE; DENDRITIC CELLS; POOR-PROGNOSIS; GASTRIC-CANCER; MESSENGER-RNA; IFN-GAMMA; LNCRNA; IMMUNOTHERAPY; EXPRESSION;
D O I：
10.1002/jcp.26568
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The imbalance of immune status in cancer microenvironment plays an important role in the development and progression of cancer. Immunotherapy based on this has become an important field of cancer research in recent years. Many studies on long noncoding RNA (lncRNA) in cancer have focus on its regulation in cancer development and metastasis. Recent studies have suggested that lncRNAs play crucial roles in different phases of cancer immunity, including antigen releasing, antigen presentation, immune activation, immune cells migration, infiltrating into cancer tissues, and killing cancer cells. The functional studies of lncRNAs in cancer immuntity revealed the complicated molecular mechanisms in cancer immunity from a new point of view, which may provide novel potential targets for cancer immunotherapies. Based on the classical cancer-immunity cycle theory, we review the recent studies on the functions and mechanisms of immune-related lncRNAs in different stages of cancer immunity, to summarize the relationship between lncRNAs, and cancer immunity and to provide a framework for further research.
引用
收藏
页码：6518 / 6523
页数：6
相关论文
共 82 条
[1]   Cancer immunotherapies, their safety and toxicity [J].
Alatrash, Gheath ;
Jakher, Haroon ;
Stafford, Patricia D. ;
Mittendorf, Elizabeth A. .
EXPERT OPINION ON DRUG SAFETY, 2013, 12 (05) :631-645
[2]   The immunoproteasome in antigen processing and other immunological functions [J].
Basler, Michael ;
Kirk, Christopher J. ;
Groettrup, Marcus .
CURRENT OPINION IN IMMUNOLOGY, 2013, 25 (01) :74-80
[3]   Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma [J].
Bonanno, Giuseppina ;
Mariotti, Andrea ;
Procoli, Annabella ;
Folgiero, Valentina ;
Natale, Daniela ;
De Rosa, Luca ;
Majolino, Ignazio ;
Novarese, Linda ;
Rocci, Alberto ;
Gambella, Manuela ;
Ciciarello, Marilena ;
Scambia, Giovanni ;
Palumbo, Antonio ;
Locatelli, Franco ;
De Cristofaro, Raimondo ;
Rutella, Sergio .
JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
[4]   Regulation of Transcription by Long Noncoding RNAs [J].
Bonasio, Roberto ;
Shiekhattar, Ramin .
ANNUAL REVIEW OF GENETICS, VOL 48, 2014, 48 :433-455
[5]   Real-world data on nivolumab treatment of non-small cell lung cancer [J].
Brustugun, O. T. ;
Sprauten, M. ;
Helland, A. .
ACTA ONCOLOGICA, 2017, 56 (03) :438-440
[6]   A Long Noncoding RNA Mediates Both Activation and Repression of Immune Response Genes [J].
Carpenter, Susan ;
Aiello, Daniel ;
Atianand, Maninjay K. ;
Ricci, Emiliano P. ;
Gandhi, Pallavi ;
Hall, Lisa L. ;
Byron, Meg ;
Monks, Brian ;
Henry-Bezy, Meabh ;
Lawrence, Jeanne B. ;
O'Neill, Luke A. J. ;
Moore, Melissa J. ;
Caffrey, Daniel R. ;
Fitzgerald, Katherine A. .
SCIENCE, 2013, 341 (6147) :789-792
[7]   Elements of cancer immunity and the cancer-immune set point [J].
Chen, Daniel S. ;
Mellman, Ira .
NATURE, 2017, 541 (7637) :321-330
[8]   Oncology Meets Immunology: The Cancer-Immunity Cycle [J].
Chen, Daniel S. ;
Mellman, Ira .
IMMUNITY, 2013, 39 (01) :1-10
[9]   Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1 [J].
Chiba, Shigeki ;
Baghdadi, Muhammad ;
Akiba, Hisaya ;
Yoshiyama, Hironori ;
Kinoshita, Ichiro ;
Dosaka-Akita, Hirotoshi ;
Fujioka, Yoichiro ;
Ohba, Yusuke ;
Gorman, Jacob V. ;
Colgan, John D. ;
Hirashima, Mitsuomi ;
Uede, Toshimitsu ;
Takaoka, Akinori ;
Yagita, Hideo ;
Jinushi, Masahisa .
NATURE IMMUNOLOGY, 2012, 13 (09) :832-842
[10]   Regulation of the Th1 Genomic Locus from Ifng through Tmevpg1 by T-bet [J].
Collier, Sarah P. ;
Henderson, Melodie A. ;
Tossberg, John T. ;
Aune, Thomas M. .
JOURNAL OF IMMUNOLOGY, 2014, 193 (08) :3959-3965
123456789